Page last updated: 2024-09-04

pomalidomide and interleukin-8

pomalidomide has been researched along with interleukin-8 in 1 studies

Compound Research Comparison

Studies (pomalidomide)	Trials (pomalidomide)	Recent Studies (post-2010) (pomalidomide)	Studies (interleukin-8)	Trials (interleukin-8)	Recent Studies (post-2010) (interleukin-8)
623	121	552	23,523	1,167	9,990

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Begna, K; Finke, C; Lasho, T; Pardanani, A; Tefferi, A	1

Trials

1 trial(s) available for pomalidomide and interleukin-8

Article	Year
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis. American journal of hematology, 2011, Volume: 86, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anemia; Chemokine CCL2; Cytokines; Female; Humans; Interleukin-15; Interleukin-8; Janus Kinase 1; Janus Kinase 2; Male; Middle Aged; Mutation; Predictive Value of Tests; Primary Myelofibrosis; Receptors, Interleukin-2; Thalidomide; Treatment Outcome	2011

Article

Year

Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.

American journal of hematology, 2011, Volume: 86, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Anemia; Chemokine CCL2; Cytokines; Female; Humans; Interleukin-15; Interleukin-8; Janus Kinase 1; Janus Kinase 2; Male; Middle Aged; Mutation; Predictive Value of Tests; Primary Myelofibrosis; Receptors, Interleukin-2; Thalidomide; Treatment Outcome

2011